key: cord-1044805-4l2ytpib
authors: Zaidat, Osama O.; Liebeskind, David S.; Jadhav, Ashutosh P.; Ortega-Gutierrez, Santiago; Nguyen, Thanh N.; Haussen, Diogo C.; Yavagal, Dileep R.; Froehler, Michael T.; Jahan, Reza; Nogueira, Raul G.; Yao, Tom L.; Alenzi, Bader A.; Bushnaq, Saif; Mueller-Kronast, Nils H.
title: Impact of Age and Alberta Stroke Program Early Computed Tomography Score 0 to 5 on Mechanical Thrombectomy Outcomes: Analysis From the STRATIS Registry
date: 2021-06-03
journal: Stroke
DOI: 10.1161/strokeaha.120.032430
sha: b987b79ab3aadbda586eed5e0fa1feb2995e9500
doc_id: 1044805
cord_uid: 4l2ytpib

BACKGROUND AND PURPOSE: This study investigates clinical outcomes after mechanical thrombectomy in adult patients with baseline Alberta Stroke Program Early CT Score (ASPECTS) of 0 to 5. METHODS: We included data from the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke) from patients who underwent mechanical thrombectomy within 8 hours of symptom onset and had available ASPECTS data adjudicated by an independent core laboratory. Angiographic and clinical outcomes were collected, including successful reperfusion (modified Thrombolysis in Cerebral Infarction ≥2b), functional independence (modified Rankin Scale score 0–2), 90-day mortality, and symptomatic intracranial hemorrhage at 24 hours. Outcomes were stratified by ASPECTS scores and age. RESULTS: Of the 984 patients enrolled, 763 had available ASPECTS data. Of these patients, 57 had ASPECTS of 0 to 5 with a median age of 63 years (interquartile range, 28–100), whereas 706 patients had ASPECTS of 6 to 10 with a median age of 70 years of age (interquartile range, 19–100). Ten patients had ASPECTS of 0 to 3 and 47 patients had ASPECTS of 4 to 5 at baseline. Successful reperfusion was achieved in 85.5% (47/55) in the ASPECTS of 0 to 5 group. Functional independence was achieved in 28.8% (15/52) in the ASPECTS of 0 to 5 versus 59.7% (388/650) in the 6 to 10 group (P<0.001). Mortality rates were 30.8% (16/52) in the ASPECTS of 0 to 5 and 13.4% (87/650) in the 6 to 10 group (P<0.001). sICH rates were 7.0% (4/57) in the ASPECTS of 0 to 5 and 0.9% (6/682) in the 6 to 10 group (P<0.001). No patients aged >75 years with ASPECTS of 0 to 5 (0/12) achieved functional independence versus 44.8% (13/29) of those age ≤65 (P=0.005). CONCLUSIONS: Patients <65 years of age with large core infarction (ASPECTS 0–5) have better rates of functional independence and lower rates of mortality compared with patients >75 years of age. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02239640.

Association/American Stroke Association guidelines. 1, 2 These guidelines are based on several randomized clinical trials and endovascular therapy trials demonstrating superior efficacy of mechanical thrombectomy (MT) Stroke. 2021;52:2220-2228. DOI: 10.1161/STROKEAHA.120. 032430 July 2021 2221 CLINICAL AND POPULATION SCIENCES compared with medical therapy. [3] [4] [5] [6] [7] [8] [9] [10] However, the presenting core infarction volume beyond which MT is futile or potentially harmful has not been established. [11] [12] [13] Data supporting MT use on low ASPECTS of 0 to 5 and its associated clinical outcomes is not conclusive, possibly due to the low volume of salvageable brain tissue and large core infarct volume, both of which predict a low functional independence rate and higher symptomatic intracranial hemorrhage (sICH) rate. [11] [12] [13] See related article, p 2229

In this study, we evaluated clinical outcomes in patients with AIS undergoing MT and presenting with large core infarct volume, as determined by a low ASPECTS (0-5), in the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke). 14 We aimed to assess whether low ASPECTS was associated with worse functional outcome and higher rates of sICH compared with patients with higher ASPECTS. Furthermore, because advanced age is associated with low rates of functional independence and high rates of sICH and mortality, [15] [16] [17] we studied the combined effect of ASPECTS on the clinical outcome of MT stratified by age.

Requests for data access may be sent to the corresponding author.

The STRATIS registry was a prospective, single-arm, multicenter, nonrandomized, observational study that evaluated the use of Solitaire Revascularization Device (Solitaire, Medtronic, Minneapolis, MN) and Mindframe Capture Low profile Revascularization (Mindframe, Medtronic, Minneapolis, MN) in 1000 patients with anterior circulation emergent large vessel occlusion at 55 centers within the United States between August 2014 and June 2016. Ethic committees and institutional review boards approval was obtained at each medical center. Subjects were provided a written informed consent before enrollment. The details and results of the STRATIS Registry are published elsewhere. 14 Patients who underwent MT per the study protocol were included based on the following inclusion criteria: (1) availability of ASPECTS before thrombectomy; (2) availability of angiographic data and clinical outcomes; (3) confirmed symptomatic intracranial emergent large vessel occlusion involving the internal carotid artery terminus or proximal middle cerebral artery; (4) confirmed National Institutes of Health Stroke Scale (NIHSS) scores of 8 to 30; (5) use of Medtronic marketreleased neurothrombectomy device as the initial device; (6) premorbid modified Rankin Scale (mRS) score of ≤1; and (7) arterial puncture within 8 hours of stroke onset.

Angiographic procedural images, baseline images (before MT), and follow-up (after MT) parenchymal noncontrast computed tomography (NCCT) images were evaluated by an independent core laboratory blinded to clinical outcomes data. NCCT was evaluated, interpreted, and an Imaging Report Form was completed by an experienced physician (D.S. Liebeskind) using the ASPECTS scoring system. The reader evaluated each of the ten ASPECTS regions using all imaged slices. 18 After adjusting the window and level setting to optimize ASPECTS grading, a region was scored negatively if an early ischemic change with clear hypoattenuation or loss of gray-white matter differentiation was identified. Areas with early ischemic signs were deducted from the total ASPECTS of 10 to obtain the final ASPECTS score.

Based on the core lab adjudicated baseline NCCT ASPECTS, patients were grouped using traditional dichotomization (ASPECTS 0-5 versus 6-10 groups), as well as a trichotomized scheme (ASPECTS 0-3 [very large stroke], 4-5 [moderate/large core infarct], and 6-10 [small/moderate core infarct] groups). The ASPECTS of 0 to 5 group was further stratified based on patient age at presentation in 3 groups (≤65 versus >65-75 versus >75).

The primary outcome was functional independence (mRS score 0-2) at 90 days. Angiographic outcomes included (1) successful reperfusion (modified Thrombolysis in Cerebral Infarction ≥2b) and (2) complete reperfusion (modified Thrombolysis in Cerebral Infarction 3). Technical and procedural outcomes included (1) first-pass effect (achieving modified Thrombolysis in Cerebral Infarction ≥2b in the first pass), 19 (2) number of passes, (3) use of rescue therapy, (4) embolization into new territory, and (5) 

with associated NIHSS score worsening of 4 or more points) based on 24-hour-NCCT post-MT.

Student t tests were used for normally distributed continuous variables, the Mann-Whitney test was used for ordinal or nonnormal variables, and Fisher exact or χ 2 tests were used for categorical variables. Multivariate analysis was performed via stepwise logistic regression. Initial variable selection included successful recanalization, sICH, IV tPA (intravenous tissue-type plasminogen activator), ASPECTS and those with P<0.1 from univariate analyses. All analyses were performed by an independent statistician using SAS software (SAS Institute, Cary, NC). P<0.05 were considered significant. All supporting data from this study are available within the article.

Of the 984 patients enrolled in the STRATIS Registry, 763 (77.5%) had NCCT ASPECTS read by the imaging core lab and were included in this study ( Figure 1 ). Of these patients, 57 (7.5%) had ASPECTS of 0 to 5 and 706 (92.5%) had ASPECTS of 6 to 10. Among the ASPECTS of 0 to 5 group, 10 (17.5%) patients had ASPECTS of 0 to 3 and 47 (82.5%) had ASPECTS of 4 to 5. Baseline variables were compared among the ASPECTS of 0 to 5, and 6 to 10 groups (Table 1) . Baseline variables further categorized into subgroups 0 to 3, 4 to 5, and 6 to 10 are found in Table I 

Procedural, angiographic, and clinical outcome comparisons are presented in Table 2 . There was no difference in successful reperfusion rate among these groups. Complete reperfusion rates were lower in the ASPECTS of 0 to 5 versus the ASPECTS of 6 to 10 group ( 

Clinical and safety outcome comparisons are presented in Table 2 . Among 57 patients with ASPECTS of 0 to 5, 90-day outcome was reported in 52 (91.2%) patients.

There was a significantly lower rate functional independence in the ASPECTS of 0 to 5 cohort versus the ASPECTS of 6 to 10 group (28.8% versus 59.7%; P<0.001). There was no difference in functional independence rates between the ASPECTS of 0 to 3 group and the ASPECTS of 4 to 5 group ( 

Procedural, clinical, and safety outcome comparisons are presented in Table 3 . There was no difference in baseline 

ASPECT 0 to 3 (P=0.039) and 4 to 5 (P=0.007) were independent predictors of poor functional outcome (mRS score >2) at 3 months after adjusting for age, baseline NIHSS, successful reperfusion, sICH, onset (Table 4 ).

Our study showed that ASPECTS of 0 to 5 is associated with a low good functional outcome rate and high mortality rate in patients >75 years, indicating a lower clinical benefit of MT in this patient population. Conversely, patients ≤65 years of age with ASPECTS of 0 to 5, had similar rates of both good functional outcome and mortality relative to the overall patient population and were significantly better than patients >75 years. Younger age, low baseline NIHSS score, absence of symptomatic ICH, and early time from onset to groin puncture were each shown to be important and independent predictors of good functional outcome; accordingly, regardless of ASPECTS score, patients demonstrating these characteristics are likely to have favorable prognosis.

ASPECTS as a surrogate marker of core infarct volume correlates with clinical outcomes in patients with AIS. 18 However, the exact ASPECT score beyond which there is no clinical benefit from MT is not well-established since most recent clinical trials excluded patients with low ASPECTS (0-5). 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] 13 Limited data with small sample sizes preclude our ability to address this question that has both clinical and health care cost-related consequences. 20 This is also a high-priority research question according to the Stroke Therapy Academic Industry Roundtable group. 21 The low good functional outcome rate in patients with low ASPECTS is consistent with other studies. In a metaanalysis of 13 articles correlating baseline ASPECTS with clinical outcomes, mRS score of 0 to 2 was achieved in 17.1%, 35.7%, and 49.7% in the low (0-4), intermediate (5) (6) (7) , and high (8-10) ASPECTS groups, respectively. 22 Another meta-analysis of 17 studies reported mRS score of 0 to 2 for 1378 patients with ASPECTS of 0 to 6; mRS score of 0 to 2 rate was 37.7% for ASPECTS of 6, 33.3% for ASPECTS of 5, 22.1% for ASPECTS of 4, 17.1% for 24 However, there was no remarkable benefit of MT for patients with ASPECTS of 0 to 2 (0% in MT versus 12% in the control group (adjusted OR, 0.00 [CI, 0.00-5.81]). 24 In the MR-CLEAN trial (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands), 6% (30/496) patients with ASPECTS of 0 to 4 were enrolled; 11 (36.7%) in the MT and 19 (6.3%) in the IV tPA treatment group, and mRS score of 0 to 2 was achieved in 1/11 (9%) of patients in the MT group versus 0/19 (0%) in the control group at 90 days. 13 These data suggest marginal or potentially no benefit of MT in patients with ASPECTS of 0 to 2 or 0 to 3. However, nonrandomized studies and meta-analyses evaluating the clinical benefit of MT in patients with low ASPECTS have mixed results, with some studies demonstrating improvement after MT even in patients with incomplete or failed recanalization, while others suggest MT is not beneficial in patients with low ASPECTS. 13, [22] [23] [24] [25] We showed that mortality rate increased with decreasing baseline ASPECTS; however, there was a significant increase in sICH rate in both the ASPECTS of 0 to 6 versus 6 to 10 and ASPECTS of 4 to 5 versus 6 to 10 groups. However, the HERMES analysis of ASPECTS of 0 to 4 patients showed a higher sICH rate in the MT group ( 24 However, in the MR-CLEAN trial, the ASPECTS of 0 to 4 cohort did not show a significant difference in rates of sICH or 90-day mortality (4/11 [36%] in the MT group versus 8/19 [42%] in the IV tPA group). 13 Although advanced age is associated with worse outcome, patients with advanced age still benefit from MT compared with those treated with IV tPA alone. 15, 24 Conversely, in the present study, functional independence rate decreased with increasing age in patients with low ASPECTS. This is consistent with the reduced good outcome (mRS score 0-2) rate in patients aged >70 years versus those aged <70 years (16.2% versus 40.3%, respectively), as reported in a recent meta-analysis by Cagnazzo et al. 23 Additionally, in the low ASPECTS (0-5) subgroup analysis of the RESCUE-Japan (Recovery by Endovascular Salvage for Cerebral Ultra-Acute Embolism) Registry 2, patients aged <75 years were more likely to have favorable outcome with MT (OR, 2.43 [CI, 0.98-6.01]) versus those aged ≥75 years (OR, 2.11 [CI, 0.51-8.78]). 26 Danière et al 27 conducted a low diffusion-weighted imaging-ASPECT (<5) study, reporting that only 10% (12/120) of patients >70 years achieved good outcome (mRS score 0-2). In an analysis of the MR-CLEAN registry, the authors found that there was no significant interaction between age and ASPECTS on mRS outcomes, indicating that endovascular therapy should not be withheld from elderly patients with low ASPECTS. 28 However, the authors did report an increased chance of sICH in elderly patients (age >71.8 years) with low ASPECTS. 28 One limitation of our study is that patients from the STRATIS Registry with NCCT ASPECTS that were read by an independent core lab (763/984 [77.5%]) only, yielding low ASPECTS treated rate with MT of 7.5%. However, this number is consistent with low ASPECTS patient enrollment rate of 6% and 10% in the MR-CLEAN trial and HERMES 

collaborative meta-analysis, respectively. 13, 24 Moreover, the stratification of ASPECTS of 0-3 treated with MT only contained ten patients, making it difficult to draw conclusions from such a small sample size. Because our study uses registry-based data with less stringent criteria than randomized controlled trials, there are inherent selection biases. Additionally, we restricted the ASPECTS analysis on NCCT versus using diffusion-weighted imaging-ASPECTS, which may have yielded different efficacy and safety results of MT. 27 Our analysis also did not analyze infarcts by topographical region. The analysis of the NCCT by a single physician is a limitation, due to variation in ASPECTS analysis between observers. 29 Future research may include artificial intelligence semi-quantification of ASPECT score using unapproved tools that are currently available for research only such as RAPID-ASPECTS, e-ASPECTS, or VIZ-AI-ASPECTS. Another limitation is that low ASPECTS may not be as predictive of ischemic core volume, which has been reported with diffusion-weighted imaging-ASPECTS. 29 

Our study demonstrated poor MT outcomes for AIS patients with low baseline ASPECTS (0-5), with poor functional independence rate and high rates of mortality and sICH. Moreover, patients with ASPECTS of 0 to 3 and patients >75 years of age had worse rates of functional independence and mortality among patients with ASPECTS of 0 to 5. Prospective randomized studies are warranted to establish the impact of low ASPECTS on MT outcomes in patients with AIS.

guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the

American Heart Association Council on Cardiovascular Radiology and Intervention and Stroke Council. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the

Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging

A randomized trial of intraarterial treatment for acute ischemic stroke

Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial

EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection

Randomized assessment of rapid endovascular treatment of ischemic stroke

REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke

DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct

Stentretriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke

Mechanical thrombectomy in ischemic stroke patients with alberta stroke program early computed tomography score 0-5

Favorable revascularization therapy in patients with ASPECTS ≤ 5 on DWI in anterior circulation stroke

Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)

Systematic evaluation of patients treated with neurothrombectomy devices for acute ischemic stroke: primary results of the STRATIS Registry

Influence of age on clinical and revascularization outcomes in the North American Solitaire Stent-Retriever Acute Stroke Registry

DEFUSE 2 Investigators. A score based on age and DWI volume predicts poor outcome following endovascular treatment for acute ischemic stroke

Mechanical thrombectomy for acute ischemic stroke in octogenarians: a systematic review and meta-analysis

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy

First pass effect: a new measure for stroke thrombectomy devices

Clinical imaging factors associated with infarct progression in patients with ischemic stroke during transfer for mechanical thrombectomy

Stroke Treatment Academic Industry Roundtable) Writing Contributors. STAIR X: trial design considerations and additional populations to expand indications for endovascular treatment Stroke

Influence of ASPECTS and endovascular thrombectomy in acute ischemic stroke: a meta-analysis

Mechanical thrombectomy in patients with acute ischemic stroke and ASPECTS ≤6: a meta-analysis

Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patientlevel data

Incomplete or failed thrombectomy in acute stroke patients with Alberta Stroke Program Early Computed Tomography Score 0-5 -how harmful is trying?

Impact of endovascular therapy in patients with large ischemic core: subanalysis of recovery by endovascular salvage for Cerebral Ultra-Acute Embolism Japan Registry 2

Patient selection for stroke endovascular therapy-DWI-ASPECTS thresholds should vary among age groups: insights from the recost study

Combined effect of age and baseline alberta stroke program early computed tomography score on post-thrombectomy clinical outcomes in the MR CLEAN Registry

Use of diffusion-weighted imaging-alberta stroke program early computed tomography score (DWI-ASPECTS) and ischemic core volume to determine the malignant profile in acute stroke

We acknowledge Oscar H. Bolanos, Medtronic, and Meliza Ward (St Vincent Hospital) for editorial support. 

Online Tables I-II